Dr. Julie Frearson serves as Chief Scientific Officer at Charles River Laboratories, where she oversees the integration of AI-driven approaches into preclinical research and drug discovery services. She brings over 25 years of experience in drug discovery and development, having previously held leadership positions at Millennium Pharmaceuticals and the Cancer Research UK Cambridge Institute. Dr. Frearson's work focuses on validating computational predictions in experimental systems, bridging the gap between AI-generated hypotheses and real-world biological validation.